Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Naloxon

A tale of two opioid antidotes

A tale of two opioid antidotes

NEW OVERDOSE REVERSAL MED — The FDA this week approved a new product to reverse opioid overdoses, but some harm-reduction experts say it’s an unnecessary tool that could pose more risks than benefits. (Politico, USA, 09.08.2024)

https://www.politico.com/newsletters/prescription-pulse/2024/08/09/a-tale-of-two-opioid-antidotes-00173365